|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.380 CNY | +0.23% |
|
+0.69% | -20.80% |
| 05-25 | North China Pharma Gets China Nod for Kidney Anemia Drug | MT |
| 04-24 | North China Pharmaceutical Company.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 7.51B 1.11B 969M 893M 840M 1.57B 105B 1.58B 10.62B 4.13B 51.63B 4.17B 4.08B 179B | P/E 2024 |
69.9x | P/E 2025 | 51.7x |
|---|---|---|---|---|---|
| Enterprise Value | 17.19B 2.54B 2.22B 2.04B 1.92B 3.59B 240B 3.62B 24.3B 9.44B 118B 9.54B 9.34B 409B | EV / Sales 2024 |
1.89x | EV / Sales 2025 | 2.07x |
| Free-Float |
40.02% | Yield 2024 |
0.58% | Yield 2025 | 0.63% |
| 1 day | +0.23% | ||
| 1 week | +0.69% | ||
| Current month | -3.52% | ||
| 1 month | -11.87% | ||
| 3 months | -21.93% | ||
| 6 months | -22.34% | ||
| Current year | -20.80% |
| 1 week | 4.31 |  | 4.55 |
| 1 month | 4.3 | | 4.96 |
| Current year | 4.3 | | 6.07 |
| 1 year | 4.3 | | 7.46 |
| 3 years | 3.83 | | 7.46 |
| 5 years | 3.83 | | 13.45 |
| 10 years | 3.83 | | 20.24 |
| Manager | Title | Age | Since |
|---|---|---|---|
Min Zhang
CEO | Chief Executive Officer | 55 | 28/11/2025 |
Zhi Guang Xiao
DFI | Director of Finance/CFO | 46 | 10/04/2024 |
Jing Yang
IRC | Investor Relations Contact | 45 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Yao Cao
CHM | Chairman | 49 | 22/03/2016 |
Li Xin Wang
CHM | Chairman | 54 | 10/04/2023 |
Ji Gang Xie
BRD | Director/Board Member | 53 | 23/04/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/02/25 | Buy | Chairman | 1,600 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.23% | +0.69% | -30.37% | -22.48% | 1.11B | |
| -1.21% | -5.37% | +39.94% | +145.38% | 980B | |
| -2.48% | -4.17% | +51.52% | +39.07% | 550B | |
| -2.14% | -3.68% | +16.71% | +56.15% | 382B | |
| -2.30% | +0.25% | +25.86% | +16.53% | 317B | |
| +1.00% | -1.44% | +25.74% | +13.93% | 270B | |
| +0.78% | -2.46% | +25.07% | +31.07% | 269B | |
| +4.97% | +2.44% | -39.75% | -45.65% | 191B | |
| -1.19% | -4.65% | +16.56% | +47.00% | 182B | |
| -1.35% | -1.68% | +14.59% | +56.94% | 154B | |
| Average | -0.38% | -2.64% | +14.59% | +33.79% | 329.52B | |
| Weighted average by Cap. | -0.95% | -3.38% | +28.34% | +64.13% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 9.87B 1.46B 1.27B 1.17B 1.1B 2.06B 138B 2.08B 13.95B 5.42B 67.81B 5.48B 5.36B 235B | 9.24B 1.37B 1.19B 1.1B 1.03B 1.93B 129B 1.95B 13.06B 5.07B 63.5B 5.13B 5.02B 220B |
| Net income | 127M 18.79M 16.37M 15.09M 14.19M 26.55M 1.77B 26.74M 180M 69.72M 873M 70.51M 69M 3.02B | 183M 27.08M 23.59M 21.75M 20.46M 38.27M 2.55B 38.54M 259M 100M 1.26B 102M 99.47M 4.36B |
| Net Debt | 9.79B 1.45B 1.26B 1.16B 1.09B 2.05B 136B 2.06B 13.84B 5.37B 67.26B 5.44B 5.32B 233B | 9.67B 1.43B 1.25B 1.15B 1.08B 2.02B 135B 2.04B 13.67B 5.31B 66.47B 5.37B 5.26B 230B |
Employees
9,972
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/06/26 | 4.380 ¥ | +0.23% | 9,442,301 |
| 17/06/26 | 4.370 ¥ | -1.35% | 9,296,506 |
| 16/06/26 | 4.430 ¥ | -1.34% | 9,762,000 |
| 15/06/26 | 4.490 ¥ | +0.22% | 13,249,510 |
| 12/06/26 | 4.480 ¥ | +2.99% | 14,514,800 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600812 Stock
Select your edition
All financial news and data tailored to specific country editions
